Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains

References

• Sabin AB. Epidemiologic patterns of poliomyelitis in different parts of the world. Poliomyelitis: Papers and Discussions Presented at the First International Poliomyelitis Conference; 1949; Philadelphia (PA): JB Lippincott; p. 3–33.
   Google Scholar
• Lambert SM, Markel H. Making history: thomas Francis, Jr, MD, and the 1954 Salk poliomyelitis vaccine field trial. Arch Pediatr Adolesc Med. 2000;154(5):512–17. doi:10.1001/archpedi.154.5.512.
   PubMedGoogle Scholar
• Sabin AB. Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis. 1985;151:420–36.
   PubMed Web of Science ®Google Scholar
• Agol VI. Vaccine-derived polioviruses. Biologicals. 2006;34(2):103–08. doi:10.1016/j.biologicals.2006.02.007.
   PubMed Web of Science ®Google Scholar
• Kew OM, Sutter RW, Gourville EMD, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587–635. doi:10.1146/annurev.micro.58.030603.123625.
   PubMed Web of Science ®Google Scholar
• Platt LR, Estivariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. J Infect Dis. 2014;210(Suppl 1):S380–9. doi:10.1093/infdis/jiu184.
   PubMed Web of Science ®Google Scholar
• Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis. 2014;210(Suppl 1):S283–93. doi:10.1093/infdis/jiu295.
   PubMed Web of Science ®Google Scholar
• World Health Organization. FACT FILE: polio Eradication and Endgame Strategic Plan 2013-2018. Global Polio Eradication Initiative. Geneva (Switzerland): WHO; 2012.
   Google Scholar
• Minor P. Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine. 2009;27(20):2649–52. doi:10.1016/j.vaccine.2009.02.071.
   PubMed Web of Science ®Google Scholar
• Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Mwanza M, Corander J, Garnier S, Chauvin C, Abanida E, Pate MA, et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med. 2010;362(25):2360–69. doi:10.1056/NEJMoa0910074.
   PubMed Web of Science ®Google Scholar
• Prevots DR, Burr RK, Sutter RW, Murphy TV. Advisory committee on immunization practices. Poliomyelitis prevention in the United States. Updated recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2000;49:1–22.
   PubMedGoogle Scholar
• Liao G, Li R, Li C, Sun M, Li Y, Chu J, Jiang S, Li Q. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial. J Infect Dis. 2012;205(2):237–43. doi:10.1093/infdis/jir723.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for the safe production and quality control of inactivated poliomyelitis vaccine manufactured from wild polioviruses. 2003 Addendum to the Recommendations for the production and quality control of poliomyelitis vaccine (inactivated) WHO Technical Report Series 2004; Annex 2 No. 926.; [ Accessed Nov 24 2011]. http://www.who.int/mediacentre/factsheets/fs114/en/.
   Google Scholar
• Verdijk P, Rots NY, van Oijen MG, Oberste MS, Boog CJ, Okayasu H, Sutter RW, Bakker WAM. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults. Vaccine. 2013 Nov 12;31(47):5531–36. doi:10.1016/j.vaccine.2013.09.021.
   PubMed Web of Science ®Google Scholar
• Chu K, Ying Z, Wang L, Hu Y, Xia J, Chen L, Wang J, Li C, Zhang Q, Gao Q, et al. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trial. Vaccine. 2018 Oct 29;36(45):6782–89. doi:10.1016/j.vaccine.2018.09.023.
   PubMed Web of Science ®Google Scholar
• Sormunen H, Stenvik M, Eskola J, Hovi T. Age- and dose-interval-dependent antibody responses to inactivated poliovirus vaccine. J Med Virol. 2001;63:305–10.
   PubMed Web of Science ®Google Scholar
• Linder N, Handsher R, German B, Sirota L, Bachman M, Zinger S, Mendelson E, Barzilai A. Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth. Arch Dis Childhood Fetal Neonatal Ed. 2000;83(1):F24–7. doi:10.1136/fn.83.1.F24.
   PubMedGoogle Scholar
• Asturias EJ, Dueger EL, Omer SB, Melville A, Nates SV, Laassri M, Chumakov K, Halsey NA. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants. J Infect Dis. 2007;196(5):692–98. doi:10.1086/520546.
   PubMed Web of Science ®Google Scholar
• Dayan GH, Thorley M, Yamamura Y, Rodriguez N, Mclaughlin S, Torres LM, Seda A, Carbia M, Alexander LN, Caceres V, et al. Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico. J Infect Dis. 2007;195(1):12–20. doi:10.1086/508427.
   PubMed Web of Science ®Google Scholar
• Yu WZ, Wen N, Zhang Y, Wang HB, Fan CX, Zhu SL, Xu W-B, Liang X-F, Luo H-M, Li L. Poliomyelitis eradication in China: 1953-2012. J Infect Dis. 2014;210(Suppl 1):S268–74. doi:10.1093/infdis/jit332.
   PubMedGoogle Scholar
• Liao G, Li R, Li C, Sun M, Jiang S, Li Y, Mo Z, Xia J, Xie Z, Che Y, et al. Phase 3 trial of a Sabin strain-based inactivated poliovirus vaccine. J Infect Dis. 2016;214(11):1728–34. doi:10.1093/infdis/jiw433.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Manual for the virological investigation of polio. WHO/EPI/GEN/97.01; 1997 [ Accessed Nov 24 2011]. http://www.who.int/mediacentre/factsheets/fs114/en/.
   Google Scholar